| Bioactivity | Cbz-Ala-Ala-Asn TFA is a peptide that designed based on the sequence of the substrate of legumain. Legumain is a cysteine protease. Cbz-Ala-Ala-Asn TFA can be applied as a scaffold for drug delivery[1][2]. | ||||||
| Name | Cbz-Ala-Ala-Asn TFA | ||||||
| Formula | C20H25F3N4O9 | ||||||
| Molar Mass | 522.43 | ||||||
| Appearance | Solid | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
||||||
| Reference | [1]. Shan L. Cy5-labeled aza-peptidyl Pro-Asn epoxide. 2010 May 12 [updated 2010 Jun 3]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. [2]. Poreba M. Recent advances in the development of legumain-selective chemical probes and peptide prodrugs. Biol Chem. 2019 Nov 26;400(12):1529-1550. |